We talk Nimona with Chloë Grace Moretz, Riz Ahmed, Eugene Lee Yang, ND Stevenson, Nick Bruno, and Troy Quane.
After seven years of toil and trouble, a cancelation by Disney, and resurrection by Annapurna and Netflix, ND Stevenson’s Nimona is finally ready to make a splash on the small screen. Nimona is a larger-than-life tale of identity, othering, acceptance, and finding ways to stand out in a world that fears what it does not understand. In the film, a knight in a futuristic, medieval world is framed for a crime he didn’t commit. The only one who can help him prove his innocence is Nimona — a mischievous teen who happens to be a shapeshifting creature he’s sworn to destroy. With brilliant animation from DNEG, Nimona leaps off the screen with style, vibrant colors, and attitude.
We had the pleasure of speaking with key members of the cast and crew, including Nimona creator ND Stevenson, directors Nick Bruno and Troy Quane, and lead actors Chloë Grace Moretz (Nimona), Riz Ahmed (Ballister Boldheart), and Eugene Lee Yang (Ambrosius Goldenloin). During our time together, we discuss Nimona‘s harrowing journey to the screen, the inspiration behind the film’s spirited performances, the story’s powerful message about identity and acceptance, and more!
Inspired by ND Stevenson‘s (She-Ra and the Princesses of Power) webcomic-turned-graphic novel, Nimona was directed by Nick Bruno and Troy Quane from a screenplay by Robert L. Baird and Lloyd Taylor (with Baird, Taylor, Bruno, and Quane receiving story credit alongside Pamela Ribon, Marc Haimes, and Keith Bunin). Here’s the synopsis: When Ballister Boldheart, a knight in a futuristic medieval world, is framed for a crime he didn’t commit, the only one who can help him prove his innocence is Nimona, a mischievous teen with a taste for mayhem — who also happens to be a shapeshifting creature Ballister has been trained to destroy. But with the entire kingdom out to get him, Nimona’s the best (or technically the only) sidekick Ballister can hope for. And as the lines between heroes, villains, and monsters start to blur, the two of them set out to wreak serious havoc — for Ballister to clear his name once and for all, and for Nimona to…just wreak serious havoc.
Hoteleus presents an unforgettable journey aboard the Copper Canyon train, a perfect blend of breathtaking landscapes, cultural immersion, food tasting, and unique adventure. Explore the sprawling vistas in the Copper Canyon train tours and the deeply rooted traditions of its indigenous people, the Raramuris, also known as the best long distance runners of the world.
PHOENIX, July 6, 2023 (Newswire.com)
-
Renowned for creating unforgettable travel experiences, Hoteleus is delighted to announce the roll-out of its new packages aboard the Copper Canyon train. This immersive expedition offers travelers an up-close and personal encounter with the expansive beauty of Mexico's Copper Canyon, a natural wonder that extends even larger and deeper than the Grand Canyon.
"Our goal at Hoteleus is to create unique travel experiences that go beyond the ordinary," commented Eddie Aguilar, Travel Designer of Hoteleus. "Our latest offering of Mexico's Copper Canyon train tours provides travelers a unique opportunity to explore one of Mexico's most beautiful landscapes and engage with its authentic culture."
Mexico's hidden gem, the Copper Canyon train, offers an unrivaled blend of adventure and awe-inspiring beauty. From exhilarating zip-lining experiences and bird-watching in lush forests, to breathtaking viewpoints showcasing panoramic vistas, Mexico's Copper Canyon is a destination like no other.
The tours to Mexico's Copper Canyon by Hoteleus meld together the thrill of adventure, a deep appreciation for culture, and moments of serene relaxation at boutique hotels. Each itinerary is curated with great precision to highlight the richness of the region and the stunning diversity of its nature.
The heart of these tours is a breathtaking journey aboard the famous Copper Canyon train known as "El Chepe Train". This historic Copper Canyon railway ride offers guests an unforgettable scenic passage through the Sierra Tarahumara, providing a distinctive perspective of the region's natural beauty.
The Copper Canyon train tour also presents an exciting chance for visitors to engage with the indigenous Rarámuri people, renowned for their impressive long-distance running abilities, brightly colored clothing, and deeply rooted traditions. Participants will be charmed by the vibrant cultural performances, local handicrafts, and delightful regional cuisine.
Hoteleus, in line with its commitment to responsible tourism, ensures these tours are conducted with utmost respect for the environment and local communities. Besides the iconic Copper Canyon train journey, the tour also includes options for hiking, mountain biking, and even hot air ballooning to get a panoramic view of the canyon.
About Hoteleus
Hoteleus, a travel and hospitality company with a progressive outlook, is dedicated to offering unique, culturally-rich, and eco-friendly travel experiences. By partnering with local communities, Hoteleus ensures a balance between visitor enjoyment and local prosperity, delivering genuine experiences that honor the region's cultural and natural heritage.
Profile Plan, a prominent health and weight management solutions provider, has announced the offering of custom-designed nutrition plans and behavioral support to aid individuals using anti-obesity medications (AOMs), commonly referred to as weight loss medications. This move aligns with the current trend towards more effective weight management strategies.
Profile Plan Nutrition & Wellness Personalized nutrition coaching and weight loss plans created by doctors, researchers and dietitians.
SIOUX FALLS, S.D., July 6, 2023 (Newswire.com)
-
As the weight management industry continues to evolve, AOMs, specifically a class of Glucagon-like-peptide-1 receptor agonists (GLP-1RAs), commonly known as GLP-1s, have shown substantial promise. Initially developed to treat Type 2 Diabetes, these medications have now become instrumental in the journey toward sustainable weight loss.
"While GLP-1s are proving to be remarkably effective, it is crucial to pair these medications with a comprehensive lifestyle and nutritional program," says Alyssa Burnison, Director of Program & Nutrition at Profile Plan. "Medication alone isn't the single solution for long-term outcomes. The importance of lifestyle modification and nutritional considerations cannot be overstated."
Profile Plan, which touts an average of 15% body weight loss for its members1, is uniquely positioned to support individuals using GLP-1s through their personalized coaching and programming services. This new approach will offer custom-designed plans to ensure essential nutritional intake and the preservation of lean body mass, particularly important due to the digestive side effects and decreased caloric intake that can occur with GLP-1 use. The program also emphasizes the importance of behavior change, including healthy eating, increased physical activity, and stress management, which are all critical factors in long-term weight management.
As an established provider of best-in-class complementary nutrition and lifestyle programming solutions, Profile Plan members are experiencing an average weight loss of 34.5 pounds when following the plan for 12 months, along with an average savings of $1,500 in medical costs within that year.
In conjunction with Profile Plan's holistic approach to weight management, physicians, healthcare systems, and other medication service providers, as well as the public, can be assured that those using or considering GLP-1s can improve weight loss outcomes, achieve long-term weight management, and enhance overall health.
"Our mission is to provide a comprehensive solution to weight management, combining advanced medications like GLP-1s with individually tailored nutritional and lifestyle plans. We believe that our approach will make a significant difference in people's lives," shares Ryan Niparts, CEO.
For more information about Profile Plan and its innovative protocol for GLP-1 users, please visit www.profileplan.com/glp1.
About Profile Plan
Profile Plan is a leading health and weight management solutions provider. Through personalized nutrition plans, one-on-one health coaching, and supportive technology, Profile Plan helps members create lifelong habits to promote improved health and sustainable weight management outcomes. Profile Plan's approach to weight management is simple, satisfying, and sustainable, ensuring quality nutrition intake, increased physical activity, and behavioral modification. To learn more, visit profileplan.com.
Contact Information:
Ryan Niparts
CEO, Profile Plan [email protected]
(716) 510-3316
Landmark Ruling by OAS Agency Rejects American Argument That the Land Claims Are Too Old and Fixing Them Would Be Too Disruptive to Non-Indigenous Settlers Living Within the Treaty Footprint
NEW YORK, July 6, 2023 (Newswire.com)
-
The Inter-American Commission on Human Rights has upheld the Onondaga Nation's right to pursue claims against the United States and New York State for the unjust taking of Indigenous lands two centuries ago without approval by the US Congress or governing authorities of the Onondaga Nation.
The landmark Admissibility ruling, issued by the IACHR which is part of the Organization of American States treaty signed by the United States and other Western Hemisphere nations, is a major step in the Onondaga's centuries-long struggle to force New York State to account for its illegal takings and subsequent sales for profit of treaty-guaranteed land that reduced the size of the Onondaga Nation from 2.5 million acres to its current 7,500 acres.
In its filings with the IACHR in response to the Onondaga complaint, the US relied on US court rulings rejecting comparable land claims by the Oneida and Cayuga Nations, sister nations to the Onondaga in the Six-Nation Haudenosaunee Confederacy. Those rulings found that Indigenous claims to ancestral lands set aside in treaties, as well as protections enshrined in the federal Trade and Intercourse Act governing the sale of Indigenous lands to non-Indigenous parties, were too old and disruptive to the non-Indigenous residents on those lands today.
In its report sent to Secretary of State Anthony Blinken and the US Permanent Representative to the OAS, the IACHR rejected that argument, noting that the OAS American Declaration on the Rights and Duties of Man gave the Onondaga standing to challenge the US's refusal to rein in the illegal land purchases in New York State, which were carried out without the approval or authorization of the governing authorities of the Haudenosaunee Confederacy or the Onondaga Nation itself.
"The passage of time does not diminish our determination to protect our people and regain our land which has sustained us for millennia," said Sid Hill, the Tadodaho (or chief) of the Onondaga Nation who heads the council overseeing the Haudenosaunee Confederacy. "Our view of life is linked to the core belief we must act to honor those seven generations in the past and serve those seven generations into the future. In this case, justice has certainly been delayed. We hope it will not be denied."
Joseph Heath, the Syracuse-based attorney representing the Onondaga Nation who has been challenging the illegal land purchases since 2005, first in American courts and later, starting in 2014, before the IACHR, applauded the IAHCR ruling.
"The Onondaga Nation welcomes this Admissibility decision by the OAS Inter-American Commission on Human Rights, because it advances the Nation's never-ending work to regain its lands and waters and the Nation's Petition which charges the United States with human rights violations for the illegal thefts of the Onondaga homelands, for the environmental devastation of those lands and for the failure of U$ courts to provide any remedy for these treaty and human rights violations," Heath said.
The IAHCR requires petitioners to exhaust legal remedies available within member states before bringing an action before it. The IAHCR Admissibility decision recognizes those legal arguments before American courts have now been exhausted because the dismissals have closed the courthouse doors, and the Americans will have to answer to the international tribunal.
The IAHCR decision allowing the Onondaga to pursue their claims against the US and New York state explicitly rejected the argument adopted by US courts that the claims were too old and disruptive to non-Indigenous settlers to be allowed to proceed.
"Regarding the United States, the Commission had previously stated that determinations by domestic bodies that historical land claims by an indigenous people would be denied based on the "extinguishment" of their land rights due to the encroachment by non-indigenous persons, and without a due process where indigenous peoples' rights and interest were adequately represented, were incompatible with the rights of equality before the law, right to fair trail and property under the American Declaration," the IAHCR ruling reads.
The Onondaga Nation and the Haudenosaunee Confederacy are relying on a series of three treaties they signed with the new United States government between 1788 and 1794, which, as the IAHCR Admissibility decision notes, "affirmed the sovereignty of the Onondaga Nation, promised to protect Onondaga lands and guaranteed the Onondaga Nation the 'free use and enjoyment' of its territory."
But between 1788 and 1822, New York State, without the required approval of the US Congress or the Onondaga governing authorities, illegally took more than 2 million acres of land and then "flipped" them for enormous profit to non-Indigenous landowners.
Their petition to the IAHCS asserts that "that the Onondaga Nation has never voluntarily conveyed, ceded, sold, given up or relinquished its title to any portion of its aboriginal territory. According to the petition, in keeping with its treaty commitments, the United States has never authorized or approved any transaction conveying Onondaga Nation land to any state, person, corporation, organization or other entity ... Generally, the petitioners assert that the State of New York engaged with unauthorized individuals to acquire the lands, and not the Onondaga Nation itself."
The IACHR ruling sets up a timetable for both the Onondaga and the US to respond to the order within four- to six-months, after which the matter will go to a formal hearing on the merits of the claim that the illegal land grab amounts to a human rights violation of the Onondaga's treaty-guaranteed right to "free use and enjoyment" of its territory.
Copy of IAHCR ruling and letter to Secretary of State Blinken available upon request.
Contact Information:
Bob Liff
Senior VP, George Arzt Communications [email protected]
917.287.7089
Ritani and HEMINCUFF Collaborate to Introduce a Luxurious Vegan Faux Crocodile Leather Lab Diamond Dog Collar, Combining Style, Sustainability, and Pet-Friendly Elegance That Is Available With Over 8 CTW of Stones
NEW YORK, July 6, 2023 (Newswire.com)
-
Ritani, a leading jewelry brand known for its transparent practices, is thrilled to announce its collaboration with HEMINCUFF, a New York City-grown fashion brand specializing in luxury vegan leather accessories. Together, they have launched a white vegan faux crocodile leather dog collar adorned by the customer's choice of three lab-grown diamond and gemstones attachment. Customers will be given the option to purchase the collar without the diamond add-on or choose between one of the available designs that in total add up to over 8 carats of diamonds.
This unique collaboration brings together the best of fine jewelry and sustainable fashion, offering pet owners a stylish and sustainable option for their beloved furry friends.
The dog collar, crafted by HEMINCUFF, features high-quality vegan faux crocodile leather that is both luxurious and cruelty-free. The white crocodile texture adds a touch of sophistication and elegance to any dog's attire, making it a statement piece for fashion-forward pet owners.
As a symbol of luxury and sustainability, the dog collar is adorned with a removable gold and diamond attachment handcrafted by Ritani in their New York manufacturing facility. Ritani's lab-grown diamonds are of exceptional quality, with the same physical, chemical, and optical properties as mined diamonds.
The diamond dog collar variations currently include:
"We are thrilled to collaborate with HEMINCUFF in launching this unique and beautiful dog collar," said Ria Papasifakis, Head of Product at Ritani. "As a brand committed to ethical business, we are excited to offer pet owners a luxurious and sustainable option that combines the finest jewelry craftsmanship with fashion-forward design."
The Ritani and HEMINCUFF collaboration dog collar comes in beautiful packaging that reflects the brands' commitment to sustainability, using recycled and eco-friendly materials. Each collar is accompanied by a certificate of authenticity, verifying the use of vegan faux crocodile leather and lab-grown diamonds.
The white vegan faux crocodile leather dog collar with the lab-grown diamond pendant is now available for purchase on Ritani's website at https://www.ritani.com/collections/dog-collars.
Contact Information:
Taylor Kelly
Director of Organic Growth & Content Strategy [email protected]
(347) 805-2522
LOS ANGELES, July 6, 2023 (Newswire.com)
-
Home of Ayahuasca, a retreat center specializing in plant medicine healing retreats in Peru, is pleased to announce the expansion of its offerings with extended retreats, now spanning from three to six months. These immersive programs have been meticulously crafted based on 15 years of experience working with experienced retreat participants to achieve profound and lasting change. This expansion comes after previously offering retreats ranging from one to four weeks for new participants.
"Our extended retreats are tailored for individuals who are seeking new paths in life, striving to make substantial changes in their lifestyle or mindset. They also offer support for those looking to overcome depression and addictions," explained Victor Breg, CEO of Home of Ayahuasca. "During the retreat, we work closely with each individual to ensure their retreat aligns with their goals and aspirations, leading to a transformative experience."
Home of Ayahuasca provides two distinct retreat formats, each designed to meet different needs and objectives.
The Solitary Reflection Retreat is ideal for individuals who are already familiar with shorter retreats and are ready to delve deeper into their introspective journey. Participants can engage in self-guided work if they possess prior knowledge or receive gentle guidance if desired. This retreat format promotes self-reliance, personal responsibility, and the development of intuitive decision-making skills.
The Integration and Daily Life Retreat is designed for individuals seeking to integrate their transformative experiences into their everyday lives. Participants engage in multiple plant medicine retreats while also participating in simple daily activities. This format allows individuals to solidify the changes, insights, and new perspectives gained during the retreat. Surrounded by Peru's serene natural landscapes, this retreat facilitates personal growth and holistic healing.
Participants in the extended retreats have the opportunity to work with experienced facilitators who guide them throughout their journey. These facilitators have in-depth knowledge of plant medicine practices and are dedicated to ensuring the well-being and progress of each participant.
"To ensure the highest standards of safety and care, we provide comprehensive pre-retreat screenings and consultations. This allows us to assess the suitability of each participant for the extended retreats and address any concerns or considerations," stated CEO Victor Breg.
To learn more about Home of Ayahuasca's extended three-to-six-month plant medicine retreats and embark on a journey of personal transformation and healing in Peru, please visit Home of Ayahuasca website.
About Home of Ayahuasca:
Home of Ayahuasca is a retreat center located in Peru, specializing in plant medicine retreats. With over 15 years of experience, its programs have been designed to support individuals in achieving profound and lasting change. Nestled amidst Peru's captivating landscapes, Home of Ayahuasca provides a safe and supportive environment for personal growth, emotional healing, and spiritual exploration.
FAM 2023 The Fibroid Foundation's 2023 Fibroid Awareness Month Events
ROCKVILLE, Md., July 6, 2023 (Newswire.com)
-
The Fibroid Foundation announces the 2023 Fibroid Awareness Month July event schedule.
The 2023 Fibroid Awareness Month Theme is "Breaking News!" All programs provide emerging insights and dynamic conversations on uterine fibroids and menstrual health. Register HERE for all programs.
Featured events are:
*July 7, 2023, at 7:00 PM EDT -Plastics and Fibroids
*July 12, 2023, at 7:00 PM EDT - Workplace Strategies for Menstrual Care
Featuring:
Milena Bacalja Perianes, Founder of HerShare, Impact Mentor at the UNICEF Venture Fund, and co-founder of Madamí.
and
Brittany Barreto, Ph.D., Co-founder and Executive Director of FemTech Focus, Host of the FemTech Focus Podcast, and President and Founder of FemHealth Insights.
*July 19, 2023, at 7:00 PM EDT - The Black Maternal Health Crisis
Dr. Veronica Gillispie-Bell, Obstetrician & Gynecologist, Associate Professor for Ochsner Health in New Orleans, Louisiana, Senior Site Lead and Section Head of Obstetrics and Gynecology at Ochsner Kenner and Director of Quality for Women's Services for the Ochsner Health System/Medical Director of the Minimally Invasive Center for the Treatment of Uterine Fibroids. Dr. Gillispie-Bell is also the Medical Director of the Louisiana Perinatal Quality Collaborative and Pregnancy Associated Mortality Review for the Louisiana Department of Health.
Tianna Madison, two-time Olympian, and three-time Olympic Track and Field Gold Medalist. Maternal health advocate.
*July 27, 2023, at 7:00 PM EDT -Fibroids and Menopause
Dr. Lauren Streicher is a clinical professor of obstetrics and gynecology at Northwestern University's Feinberg School of Medicine, a Fellow in the American College of Obstetricians and Gynecologists, a member of the Sexual Medicine Society of North America, Inc., and a Top Doctor since 2002.
Sateria Venable, Founder & CEO of The Fibroid Foundation, will moderate the panels.
The Fibroid Foundation advocates for the passage of The Stephanie Tubbs Jones Fibroid Research and Education Act - H.R. 2007 introduced in The House of Representatives by Representative Yvette D. Clarke (NY-9). The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act will provide $150M to the National Institutes of Health for fibroid research.
In the United States, an estimated 26,000,000 women between the ages of 15 and 50 have uterine fibroids.1 Uterine fibroids are the most common gynecologic condition in women2, however, treatment options and medical research funding have yet to match the enormity of the affected community.
The "Uterine Fibroids: Burden and Unmet Medical Need" 2017 study found that, "Using ultrasound screening, the estimated cumulative incidence rate of UF (uterine fibroids) by the age of 50 is significantly higher in black women (80%) compared with white women (nearly 70%)."3 Annually, uterine fibroids account for approximately half of hysterectomies performed in the United States.Data has shown that there are significant cardiovascular risk factors associated with hysterectomy.
According to The Fibroid Foundation, patients are suffering in silence. Community members express concerns about limited treatment options, the high cost of treatment, insurance coverage, and difficulty finding fibroid specialists. The organization recognizes the significant health disparities impacting its community and provides support to address them from a unique patient perspective.
The Fibroid Foundation mission:
Normalize conversations about menstruation.
Foster a movement for everyone with a uterus to thrive.
Eliminate treatment disparities with layered patient support.
Engage family and community in the menstrual health mission
Enable those diagnosed with uterine fibroids to experience a smooth path to treatment with fulfilling outcomes
Spark joy through advocacy.
Understand how and why fibroids develop, and ultimately find a cure.
About The Fibroid Foundation
The Fibroid Foundation is a global fibroid and menstrual health advocacy organization celebrating its 10th Anniversary in September 2023.
LOUISVILLE, Ky., July 6, 2023 (Newswire.com)
-
HSG Advisors, a national healthcare consulting firm, received a top 20 ranking in Modern Healthcare's 2023 Management Consulting Firms Survey results. The firms were ranked by self-reported total net healthcare revenue for 2022. In addition to quantitative metrics, the annual survey gathered industry insights on trends, challenges, and best practices from responding firms.
"HSG Advisors has grown rapidly since its founding in 1999, and we're delighted to be recognized as one of the foremost healthcare consultancies in the nation," says Travis Ansel, CEO of HSG Advisors. "We appreciate the value Modern Healthcare provides to our industry as a premier source of news and information for healthcare executives."
The survey asked companies about the state of the healthcare sector over the past year and what they foresee for the industry in the future. Notably, respondents were asked to rank which consulting type is growing the most quickly, and data analytics received the highest number of responses, at nearly 20%. This industry response is on par with HSG Advisors' own growth trajectory; its Claims Data Analytics capabilities are among its most in-demand consulting services. In the survey, data analytics outranked operational improvement, margin improvement, digital transformation, and merger and acquisition consulting.
HSG Advisors specializes in employed physician networks, providing consulting on physician strategy, leadership, and compensation, as well as network integrity and healthcare system performance. The number of employed physicians surpassed the number of physicians with their own practices in 2018, and then the pandemic significantly accelerated this trend as healthcare mergers and acquisitions and physician buyouts rose 56% from 2020 according to a study issued by the Physicians Advocacy Institute in 2021. HSG Advisors has been uniquely positioned to guide employed physicians and healthcare leaders through this pivotal time, resulting in strong year-over-year revenue growth.
About HSG Advisors
HSG Advisors is a national healthcare consulting firm headquartered in Louisville, Kentucky. The practice empowers leaders to build differentiated health system strategies and high-performing employed physician networks by pairing data intelligence with experienced advice. The firm's comprehensive approach to leveraging market facts to inform healthcare strategies allows leaders to understand opportunities and deliver the right care to their communities. For more information about HSG, visit www.HSGAdvisors.com, LinkedIn, email [email protected], or call (502) 814-1180.
OCALA, Fla., July 6, 2023 (Newswire.com)
-
Fortifeye Vitamins, a trusted leader in eye care and nutritional supplements, is shedding light on the potential benefits of omega-3 fish oil in the management of glaucoma. With a growing body of research suggesting a positive correlation between omega-3 fatty acids and glaucoma, Fortifeye Vitamins aims to raise awareness about this potential natural approach to supporting ocular health and introduce Fortifeye Super Omega 3 Max.
Glaucoma, often referred to as the "silent thief of vision," is a progressive condition that can develop unnoticed, without presenting symptoms such as pain or blurred vision, until it reaches an advanced stage. It stands as the second leading cause of blindness worldwide. The primary goal in glaucoma treatment is currently focused on reducing intraocular pressure to a manageable level, aiming to minimize optic nerve damage and prevent vision loss. Optometrists and Ophthalmologists employ a combination of oral and topical medications, as well as various surgical interventions, ranging from minimally invasive to more invasive procedures. However, many integrative primary eye care providers emphasize the importance of minimizing surgical and medication interventions whenever possible. The availability of evidence-based nutrients that can support optic nerve health and potentially slow down the progression of glaucoma would offer substantial benefits in managing the condition.
Omega-3 is a widely researched nutrient, with numerous studies highlighting its positive impact on overall health across various aspects. Extensive research consistently confirms the favorable effects of omega-3 on heart health, brain function, joint health, eye health, skin, hair, muscles, and more. Omega-3 is widely recognized as one of the top nutrients for promoting overall eye health, and knowledgeable healthcare professionals often recommend its use for conditions such as dry eye, diabetic retinopathy, macular degeneration, and various inflammatory eye conditions. Emerging evidence suggests that glaucoma, as a significant eye condition, may also experience benefits from precise dosages and appropriate forms of omega-3 supplementation.
In the past decade, a substantial amount of data has emerged regarding natural and nutritional treatments that show promise in reducing intraocular pressure and providing neuroprotection to the optic nerve, nerve fiber layer, and ganglion cell layer. Several recently highlighted nutritional components for supporting glaucoma include Mirtogenol (a combination of pine bark extract and bilberry), Cognizine (a patented variant of citicoline), omega-3 fish oil, saffron, Neumentix (a spearmint extract), and various forms of niacinamide (NMN, NR, and NAM). These components have garnered attention for their potential in supporting individuals with glaucoma.
Recent research findings indicate that a daily intake of 1500 mg (combined EPA and DHA) of omega-3 fish oil can lead to a significant reduction in intraocular pressure over a three-month period in young individuals without glaucoma. These studies revealed an impressive 8% decrease in intraocular pressure following the supplementation with omega-3 fish oil. Additionally, a study conducted on rats demonstrated a remarkable 23% reduction in intraocular pressure during the subjects' omega-3 regimen. Although the precise mechanism through which omega-3 influences glaucoma is not yet fully elucidated, several theories propose how omega-3 may effectively lower eye pressure and potentially provide neuroprotection to the optic nerve. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931260/
A correlation has been identified between glaucoma patients and reduced levels of omega-3 in their bloodstream. In a recent study, it was revealed that individuals who incorporate higher quantities of omega-3 into their daily diet exhibit a decreased likelihood of being diagnosed with glaucoma. https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2666583?redirect=true
A recent research publication from June 2023 has revealed a notable association between elevated levels of diglycerides and triglycerides in the bloodstream and an increased susceptibility to glaucoma. Recognizing this detrimental link between specific lipid abnormalities and glaucoma is crucial in developing an integrated treatment plan for glaucoma patients. One effective approach to reducing these lipids is the appropriate use of omega-3 fish oil. Omega-3 fatty acids have shown a significant ability to lower blood triglyceride levels. https://www.mountsinai.org/about/newsroom/2023/patients-with-specific-types-of-lipids-may-be-at-higher-risk-of-developing-blinding-eye-disease
Dr. Michael Lange, a renowned Optometric Physician, Certified Nutrition Specialist and founder of Fortifeye Vitamins, emphasized, "While further research is needed, there is growing evidence supporting the potential benefits of omega-3 fish oil in managing glaucoma. Omega-3 fatty acids have already demonstrated numerous health benefits, and their potential role in ocular health, specifically glaucoma management, is an exciting area of study."
Fortifeye Vitamins is a leading provider of advanced nutritional supplements designed to support eye health and overall well-being. Founded by Dr. Michael Lange, a board-certified Optometric Physician and Certified Nutrition Specialist, Fortifeye Vitamins is committed to utilizing the latest research and technology to develop effective, high-quality supplements.
Contact Information:
Mandy Baker
Director of Marketing [email protected]
3522391692
You can add this rarely showcased extreme sport to the list of death-defying stunts that Tom Cruise has done for the spy franchise.
The newest adventure of Ethan Hunt and his IMF comrades will be making its way into theaters in a couple of weeks. Recently, Tom Cruise and his frequent collaborator, Christopher McQuarrie, are championing the theater-going practice and good ol’ fashion cinematic experiences as they encourage audiences to see both Oppenheimer and Barbie to support theaters. This is in addition to their determination to give movie-goers the most thrilling entertainment for their latest outing, Mission: Impossible – Dead Reckoning Part One. The new featurette takes you behind the scenes of another giant set piece involving a little-known extreme sport called Speedflying. It’s both exactly as it sounds and exactly what you’d expect from Cruise and Company.
The official synopsis from Paramount Pictures reads, In Mission: Impossible – Dead Reckoning Part One, Ethan Hunt (Tom Cruise) and his IMF team embark on their most dangerous mission yet: To track down a terrifying new weapon that threatens all of humanity before it falls into the wrong hands. With control of the future and the fate of the world at stake, and dark forces from Ethan’s past closing in, a deadly race around the globe begins. Confronted by a mysterious, all-powerful enemy, Ethan is forced to consider that nothing can matter more than his mission – not even the lives of those he cares about most.
The new installment sports an impressive cast that includes Tom Cruise, Hayley Atwell, Ving Rhames, Simon Pegg, Rebecca Ferguson, Vanessa Kirby, Esai Morales, Pom Klementieff, Mariela Garriga, Henry Czerny, Shea Whigham, Greg Tarzan Davis, Charles Parnell, Frederick Schmidt, Cary Elwes, Mark Gatiss, Indira Varma and Rob Delaney.
Tom Cruise and Christopher McQuarrie call the shots behind the scenes as producers of the film. Executive Producers on the movie include David Ellison, Dana Goldberg, Don Granger, Tommy Gormley, Chris Brock and Susan E. Novick.
The script was written by Christopher McQuarrie & Erik Jendresen and, of course, Christopher McQuarrie returns to direct this entry as well as the next.
Your mission, should you choose to accept it, is to have fun at Mission: Impossible – Dead Reckoning Part One in theaters on July 12.
